exeporfinium   Click here for help

GtoPdb Ligand ID: 13323

Synonyms: XF-73 (exeporfinium chloride)
Compound class: Synthetic organic
Comment: Exeporfinium is a novel dicationic porphyrin antibacterial compound with activity against a wide range of Gram-positive bacteria, including Staphylococcus aureus [2,4]. We show the structure of the parent molecule here. The INN represents the chloride salt form (XF-73, CAS number 718638-68-7) and this is also the form that is under clinical evaluation.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 12
Topological polar surface area 67.24
Molecular weight 694.91
XLogP 3.7
No. Lipinski's rules broken 2

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[N+](C)(C)CCCOC1=CC=C(C=C1)C2=C3C=CC(=N3)C=C4C=CC(=C(C5=CC=C(C=C5)OCCC[N+](C)(C)C)C6=NC(=CC7=CC=C2N7)C=C6)N4
Isomeric SMILES C[N+](C)(C)CCCOC1=CC=C(C=C1)C2=C3C=CC(=CC4=NC(=C(C5=CC=C(N5)C=C6C=CC2=N6)C7=CC=C(C=C7)OCCC[N+](C)(C)C)C=C4)N3
InChI InChI=1S/C44H50N6O2/c1-49(2,3)25-7-27-51-37-17-9-31(10-18-37)43-39-21-13-33(45-39)29-35-15-23-41(47-35)44(42-24-16-36(48-42)30-34-14-22-40(43)46-34)32-11-19-38(20-12-32)52-28-8-26-50(4,5)6/h9-24,29-30,45,48H,7-8,25-28H2,1-6H3/q+2
InChI Key KZTXNPVFWHWJSH-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Farrell DJ, Robbins M, Rhys-Williams W, Love WG. (2010)
In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
Int J Antimicrob Agents, 35 (6): 531-6. [PMID:20346634]
2. Maisch T, Bosl C, Szeimies RM, Lehn N, Abels C. (2005)
Photodynamic effects of novel XF porphyrin derivatives on prokaryotic and eukaryotic cells.
Antimicrob Agents Chemother, 49 (4): 1542-52. [PMID:15793136]
3. Mangino JE, Firstenberg MS, Milewski RKC, Rhys-Williams W, Lees JP, Dane A, Love WG, Gonzalez Moreno J. (2023)
Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study.
Infect Control Hosp Epidemiol, 44 (7): 1171-1173. [PMID:36951472]
4. Ooi N, Miller K, Hobbs J, Rhys-Williams W, Love W, Chopra I. (2009)
XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity.
J Antimicrob Chemother, 64 (4): 735-40. [PMID:19689976]
5. Ooi N, Miller K, Randall C, Rhys-Williams W, Love W, Chopra I. (2010)
XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms.
J Antimicrob Chemother, 65 (1): 72-8. [PMID:19889790]